Form 4: Hims & Hers Health CEO Andrew Dudum Exercises Options and Sells Shares
SEC Form 4 Filing
Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares on May 1, 2024, according to a Form 4 filing with the SEC.
Summary
- On May 1, 2024, Andrew Dudum, CEO of Hims & Hers Health, Inc., exercised stock options to acquire 188,888 shares of Class A Common Stock at a price of $2.43 per share.
- Dudum then sold 94,444 shares at an average price of $12.5387, 94,444 shares at an average price of $12.5332, and 144,444 shares at an average price of $12.686.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 29, 2023.
- Following these transactions, Dudum directly owns no shares and indirectly owns a total of 13,366,754 shares through various trusts.
- He also directly owns 1,337,344 derivative securities (stock options).
Sentiment
Score: 5
Explanation: Neutral sentiment. The transactions are part of a pre-planned trading strategy and do not necessarily indicate a change in the CEO's confidence in the company.
Industry Context
Insider transactions are routinely scrutinized by investors as they can provide signals, though often noisy, about management's view of the company's prospects. Rule 10b5-1 plans are designed to allow insiders to trade without accusations of acting on material non-public information.
Comparison to Industry Standards
- Comparing Dudum's transactions to other CEOs in the telehealth industry is difficult without specific data on their trading activity.
- However, it's common for CEOs to have pre-arranged trading plans to diversify their holdings and manage personal finances.
- The scale of Dudum's indirect holdings through trusts is substantial, reflecting his long-term involvement with the company.
Stakeholder Impact
- The transactions could have a minor impact on shareholders due to the increased supply of shares in the market.
- However, the pre-planned nature of the transactions should mitigate any significant concerns.
Key Dates
| Date | Description |
|---|---|
| 10/15/1997 | Date of Richard M. Dudum Irrevocable 1 U/A |
| 07/02/2015 | Date of Andrew Dudum 2015 Trust |
| 11/01/2021 | Date of AD 2021 GRAT and AD 2021 GRAT 2 |
| 08/10/2021 | Date of Dudum Family Heritage Trust UAD |
| 09/07/2022 | Date of AD 2022 GRAT 2 |
| 11/28/2022 | Date of AD 2022 GRAT 3 |
| 09/05/2023 | Date of AD 2023 GRAT |
| 11/29/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 04/04/2024 | Date of previous Form 4 filing |
| 05/01/2024 | Date of stock option exercise and share sales |
| 05/03/2024 | Date of Form 4 signature |
| 06/17/2030 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.